Approved List

(Schedule to be announced..)

No. Submission ID Title
1 54 The effect of ondansetron on the efficacy of postoperativetramadol: observations from a meta-analysis of drug interaction
2 064 A multicenter, prospective study evaluating the impact of theclinical pharmacist counseling on warfarin therapy management
3 066 Designing a Feasible Method to Predict Vancomycin Trough Levelsin Pediatric Population Using Patients’ Parameters
4 073 Cannabinoids in late-onset Alzheimer’s disease
5 079 Evaluation theglinides for type 2 diabetes
6 097 Formulation and Optimization of Cationic solid lipidnanoparticles (SLNs) loaded immunogens
7 109 EVALUATION OF FILLER/BINDER PROPERTIES OF MODIFIED STARCHESDERIVED FROM PLECTRANTHUS ESCULENTUS BY DIRECT COMPRESSION IN METRONIDAZOLETABLETS FORMULATION
8 132 Comparative Bioavailability Study of Paracetamol in a Fixed-doseCombination of Paracetamol and Metoclopramide Tablets in Healthy HumanVolunteers
9 133 Exploring medication error causality and reporting: a crosssectional survey of Hamad Medical Corporation health professionals
10 134 Tribe Cynareae and Liver Disorders
11 147 Saudi community attitude and beliefs toward genetic testsAdvancement-Cross Sectional Study
12 170 Pharmacistprescribing: A historical review
13 185 Prescribing Problems and Pharmacist Interventions in CommunityPractice.
14 217 Assessment ofCINACALCET use in hemodialysis patients
15 224 Pregabalin medication use evaluation in prince sultan militarymedical city
16 235 In vivo Pharmacokinetic Evaluation of Floating Tablets ofGliclazide Employing New Polymer for Sustained Release
17 244 Protective Effect of Curcumin Against Monosodium GlutamateInduced Neurotoxicity in Rats
18 249 Formulation and evaluation of complexation of Fastdisintegrating tablet of Dimenhydrinate with Cyclodextrines
19 251 Preparation and In-Vitro/In-Vivo Evaluation of MetforminHydrochloride Rectal Dosage Form
20 259 Adenosine receptor A3 selective Agonist protects againstDoxorubicin induced Cardiotoxicity
21 261 Assessment of the Eligible Use of New Oral Anticoagulants versusAcenocoumarol in a Sample of Lebanese Patients: A Retrospective Study
22 273 Costeffectiveness of antihypertensive drug therapy
23 292 Intranasal nanoparticulate delivery of efavirenz usingchitosan-grafted-HPβCD
24 293 DRUG DOSING FOR OBESE CHILDREN, THE DUCK OR THE BIRD
25 294 dischargedpatient counseling on medication pathway
26 297 Broad Spectrum Antibiotics Use Evaluation in Surgical Floor inTertiary Care Hospital at Saudi Arabia
27 300 EVALUATION OF ADAPTOGENIC AND RELATED PROPERTIES OF G. LUCIDUMAND P. SENEGA
28 312 Medication Safety Unit Programs in King Saud Medical City, 2012– 2013: Safe medication management and use with a focus on patient safety.
29 343 International Rubric Norming for Patient-Centered CommunicationSkills
30 367 Antibiogram with the developed antibiotic policy for criticallyill patients & the 10 recommendations
31 369 High Incidence of blaOXA-23-like and blaNDM-1 in Acinetobacterbaumannii from The Eastern Region, Saudi Arabia
32 374 FACTORS AFFECTING ADHERENCE IN HYPERTENSIVE, DISLIPEMIC ANDDIABETIC PATIENTS IN THE UAE
33 383 How to implement Asthma Prevention Program? : Using ComparativeEffectiveness Research (CER) workshop
34 396 Pharmacological investigation of Date Fruit (PhoenixDactylifera, L) extract for its nootropic effect in mice
35 397 A prospective cohort study on assessment of safety profile ofwarfarin versus dabigatran in adult patients with nonvalvular atrialfibrillation treated in a secondary care hospital of Ras Al Khaimah, UAE
36 448 Malnutrition
37 485 Multi-Dose Medication Relabeling: A New Era in MedicationUtilization Process